{"DataElement":{"publicId":"6662743","version":"1","preferredName":"Hematopoietic Cell Transplantation Primary Indication Type","preferredDefinition":"A description of the primary indication for the hematopoietic cell transplant.","longName":"6662741v1.0:2771284v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6662741","version":"1","preferredName":"Hematopoietic Cell Transplantation Primary Indication","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species._Occurring first in time or sequence; original; of greatest rank or importance or value._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"2531883v1.0:6662739v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2531883","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):The grafting of tissues from one individual to another or place to place within a single individual.","longName":"C12551:C15342","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2092946C-8392-20BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-24","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-10-24","modifiedBy":"ONEDATA","dateModified":"2006-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6662739","version":"1","preferredName":"Primary Indication","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value.:A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"C25251:C41184","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83827884-9ACA-67DE-E053-F662850A7E9C","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-07","modifiedBy":"ONEDATA","dateModified":"2019-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"83827884-9ADB-67DE-E053-F662850A7E9C","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-07","modifiedBy":"KUMMEROA","dateModified":"2019-12-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2771284","version":"2","preferredName":"Hematopoietic Cell Transplantation Indication Type","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The replacement of tissue with tissue from the person's own body or from another person._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication)._Type; a subdivision of a particular kind of thing.","longName":"2771284v2.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Graft failure / rejection after achieving initial hematopoietic recovery","valueDescription":"Graft Failure Post First Hematopoietic Recovery","ValueMeaning":{"publicId":"2799998","version":"1","preferredName":"Graft Failure Post First Hematopoietic Recovery","longName":"2799998","preferredDefinition":"Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.: loss of ability to function normally.: Post; occuring after.: Preceding all others in time or space or degree.: Pertaining to or related to the formation of blood cells.: gradual healing (through rest) after sickness or injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic","conceptCode":"C13324","definition":"Pertaining to or related to the formation of blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recovery","conceptCode":"C25746","definition":"A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B96A34F-3DAA-0E90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7761-FFF2-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"No hematopoietic recovery","valueDescription":"Hematopoietic Stem Cell No Recovery","ValueMeaning":{"publicId":"2771296","version":"1","preferredName":"Hematopoietic Stem Cell No Recovery","longName":"2771296","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.): The non-affirmative response to a question.: gradual healing (through rest) after sickness or injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recovery","conceptCode":"C25746","definition":"A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F5D137-5E95-6037-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-08-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7761-FFFC-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7762-0006-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"Partial hematopoietic recovery","valueDescription":"Hematopoietic Stem Cell Partial Recovery","ValueMeaning":{"publicId":"2771294","version":"1","preferredName":"Hematopoietic Stem Cell Partial Recovery","longName":"2771294","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.): Partial; being or affecting only a part; not total: gradual healing (through rest) after sickness or injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Partial","conceptCode":"C25378","definition":"Being or affecting only a part of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recovery","conceptCode":"C25746","definition":"A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F5D137-5E5A-6037-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-08-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7762-0010-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"Persistent primary disease","valueDescription":"Persistent Primary Disease or Disorder","ValueMeaning":{"publicId":"2814269","version":"1","preferredName":"Persistent Primary Disease or Disorder","longName":"2814269","preferredDefinition":"Retained; never-ceasing.: Occurring first in time or sequence; original. (American Heritage Dictionary): Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Persistent","conceptCode":"C43623","definition":"Retained; never-ceasing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DB972E0-BB53-0AA2-E040-BB89A643568C","latestVersionIndicator":"Yes","beginDate":"2008-12-10","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7762-001A-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"Recurrent primary disease","valueDescription":"Recurrent Primary Disease or Disorder","ValueMeaning":{"publicId":"2814270","version":"1","preferredName":"Recurrent Primary Disease or Disorder","longName":"2814270","preferredDefinition":"occurring again.: Occurring first in time or sequence; original. (American Heritage Dictionary): Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DB972E0-BB7C-0AA2-E040-BB89A643568C","latestVersionIndicator":"Yes","beginDate":"2008-12-10","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7762-002E-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"Stable, mixed chimerism","valueDescription":"Mixed Stable Chimerism","ValueMeaning":{"publicId":"2770371","version":"1","preferredName":"Mixed Stable Chimerism","longName":"2770371","preferredDefinition":"Involving or composed of different kinds.: Stable; subject to little fluctuation; showing little if any change.: The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stable","conceptCode":"C30103","definition":"Subject to little fluctuation; showing little if any change.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chimerism","conceptCode":"C62582","definition":"The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53D16F04-EDD6-5CCB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7762-0038-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"Declining chimerism","valueDescription":"Loss Or Reduced Donor Chimerism","ValueMeaning":{"publicId":"2965110","version":"1","preferredName":"Loss Or Reduced Donor Chimerism","longName":"2965110","preferredDefinition":"Loss; a gradual decline in amount or activity.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Reduced; made less in size or amount or degree.: Someone who gives blood or tissue or an organ to be used in another person.: The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tissue Donor","conceptCode":"C25168","definition":"Someone who gives blood or tissue or an organ to be used in another person.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chimerism","conceptCode":"C62582","definition":"The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A26D4D5-68F1-E4C8-E040-BB89AD437B8D","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"LOHNESC","dateCreated":"2009-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E25B7762-0042-0966-E040-BB89AD434206","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"ONEDATA","dateModified":"2013-07-25","deletedIndicator":"No"},{"value":"New malignancy (including PTLD and EBV lymphoma)","valueDescription":"New Malignant Neoplasm","ValueMeaning":{"publicId":"2683453","version":"1","preferredName":"New Malignant Neoplasm","longName":"2683453","preferredDefinition":"New; having no previous example or precedent or parallel.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A97391F-357E-0F66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-20","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E990B6C0-F9FA-356B-E040-BB89AD432517","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-25","modifiedBy":"ONEDATA","dateModified":"2013-10-25","deletedIndicator":"No"},{"value":"Planned second HCT, per protocol","valueDescription":"Hematopoietic Stem Cell Second Plan Transplantation","ValueMeaning":{"publicId":"2771287","version":"1","preferredName":"Hematopoietic Stem Cell Second Plan Transplantation","longName":"2771287","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.): Coming next after the first in position in space or time or degree or magnitude.: Planned; devised, contrived, or formed in design.: The grafting of tissues from one individual to another or place to place within a single individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F5D137-5DFC-6037-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-08-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"E8C797FC-A765-37C8-E040-BB89AD436D9F","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-15","modifiedBy":"ONEDATA","dateModified":"2013-10-15","deletedIndicator":"No"},{"value":"Insufficient chimerism","valueDescription":"Inadequate Chimerism","ValueMeaning":{"publicId":"5044203","version":"1","preferredName":"Inadequate Chimerism","longName":"5044203","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement.: The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chimerism","conceptCode":"C62582","definition":"The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"244631A2-CF81-A29F-E050-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2015-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"244631A2-CF9A-A29F-E050-BB89AD43503D","beginDate":"2015-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-11","modifiedBy":"ONEDATA","dateModified":"2015-11-11","deletedIndicator":"No"},{"value":"Graft failure / insufficient hematopoietic recovery","valueDescription":"Graft Failure And/Or Inadequate Hematopoietic Recovery","ValueMeaning":{"publicId":"5044204","version":"1","preferredName":"Graft Failure And/Or Inadequate Hematopoietic Recovery","longName":"5044204","preferredDefinition":"Tissue or organ transplanted from a donor to a recipient.: A lack of occurrence or performance.: Used to indicate that either or both of two items or options may be valid.: Not meeting a quantitative or qualitative measure necessary for a requirement.: Pertaining to or related to the formation of blood cells.: A getting back or regaining.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic","conceptCode":"C13324","definition":"Pertaining to or related to the formation of blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recovery","conceptCode":"C70827","definition":"A getting back or regaining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"244631A2-CFAB-A29F-E050-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2015-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"244631A2-CFC4-A29F-E050-BB89AD43503D","beginDate":"2015-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-11","modifiedBy":"ONEDATA","dateModified":"2015-11-11","deletedIndicator":"No"},{"value":"Planned subsequent HCT, per protocol","valueDescription":"Per Protocol Plan Next Hematopoietic Stem Cell Transplantation","ValueMeaning":{"publicId":"6601256","version":"1","preferredName":"Per Protocol Plan Next Hematopoietic Stem Cell Transplantation","longName":"6601256","preferredDefinition":"For each, generally denoting a ratio.: A rule which guides how an activity should be performed.: To devise, contrive, or form in design.: Subsequent; immediately following in time or order.: Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.): Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Per","conceptCode":"C65039","definition":"For each, generally denoting a ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Protocol","conceptCode":"C42651","definition":"A rule which guides how an activity should be performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Next","conceptCode":"C53286","definition":"Subsequent; immediately following in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E7A89A6-2550-4DEF-E053-F662850A21A0","latestVersionIndicator":"Yes","beginDate":"2019-01-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-01-02","modifiedBy":"ONEDATA","dateModified":"2019-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E7A89A6-2569-4DEF-E053-F662850A21A0","beginDate":"2019-01-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-01-02","modifiedBy":"ONEDATA","dateModified":"2019-01-02","deletedIndicator":"No"},{"value":"Other reason","valueDescription":"Other Reason","ValueMeaning":{"publicId":"2965150","version":"1","preferredName":"Other Reason","longName":"2965150","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An explanation of the cause of some phenomenon or action.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A2DE37E-D327-EB88-E040-BB89AD433C75","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84AFF2ED-601C-06D9-E053-F662850A627B","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","deletedIndicator":"No"},{"value":"Stroke","valueDescription":"Cerebrovascular Accident","ValueMeaning":{"publicId":"4733294","version":"1","preferredName":"Cerebrovascular Accident","longName":"4733294","preferredDefinition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A141-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84AFF2ED-6026-06D9-E053-F662850A627B","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","deletedIndicator":"No"},{"value":"Recurrent vaso-occlusive pain","valueDescription":"Recurrent Pain Vaso-Occlusive Crisis","ValueMeaning":{"publicId":"6680602","version":"1","preferredName":"Recurrent Pain Vaso-Occlusive Crisis","longName":"6680602","preferredDefinition":"occurring again.: The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.: An exacerbation of sickle cell disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Vaso-Occlusive Crisis","conceptCode":"C122412","definition":"An exacerbation of sickle cell disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84AFF2ED-6034-06D9-E053-F662850A627B","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84AFF2ED-604D-06D9-E053-F662850A627B","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","deletedIndicator":"No"},{"value":"Recurrent priapism","valueDescription":"Recurrent Priapism","ValueMeaning":{"publicId":"6680603","version":"1","preferredName":"Recurrent Priapism","longName":"6680603","preferredDefinition":"occurring again.: Persistent and usually painful erection that lasts for at least four hours in the absence of physical or psychological stimulation, which can be caused by hematologic disorders, including sickle cell disease and leukemia, spinal cord injuries, and medications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Priapism","conceptCode":"C85022","definition":"Persistent and usually painful erection that lasts for at least four hours in the absence of physical or psychological stimulation, which can be caused by hematologic disorders, including sickle cell disease and leukemia, spinal cord injuries, and medications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84AFF2ED-605A-06D9-E053-F662850A627B","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84AFF2ED-6073-06D9-E053-F662850A627B","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","deletedIndicator":"No"},{"value":"Excessive transfusion requirements / iron overload","valueDescription":"Excessive Blood Transfusion Or Iron Overload Indication","ValueMeaning":{"publicId":"6680604","version":"1","preferredName":"Excessive Blood Transfusion Or Iron Overload Indication","longName":"6680604","preferredDefinition":"Beyond normal limits; unrestrained.: The infusion of components of blood or whole blood into the bloodstream. The blood may be donated from another person, or it may have been taken from the person earlier and stored until needed.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.: A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Excessive","conceptCode":"C73992","definition":"Beyond normal limits; unrestrained.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Blood Transfusion","conceptCode":"C15192","definition":"The injection of whole blood or a blood component directly into the bloodstream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Iron Overload","conceptCode":"C78393","definition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84AFF2ED-6083-06D9-E053-F662850A627B","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84AFF2ED-609C-06D9-E053-F662850A627B","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","deletedIndicator":"No"},{"value":"Acute chest syndrome","valueDescription":"Acute Chest Syndrome","ValueMeaning":{"publicId":"6680605","version":"1","preferredName":"Acute Chest Syndrome","longName":"6680605","preferredDefinition":"A vaso-occlusive crisis of the pulmonary vasculature occurring in patients with sickle cell disease. It is characterized by the presence of a new radiodensity on a chest radiograph accompanied by fever, cough, sputum production, dyspnea, or hypoxia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Chest Syndrome","conceptCode":"C138179","definition":"A vaso-occlusive crisis of the pulmonary vasculature occurring in patients with sickle cell disease. It is characterized by the presence of a new radiodensity on a chest radiograph accompanied by fever, cough, sputum production, dyspnea, or hypoxia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84AFF2ED-60A8-06D9-E053-F662850A627B","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84AFF2ED-60C1-06D9-E053-F662850A627B","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2771283","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation Indication Type","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):The grafting of tissues from one individual to another or place to place within a single individual.:A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).:Type; a subdivision of a particular kind of thing.","longName":"C12551:C15342:C41184:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F5D137-5D8B-6037-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-08","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-08-08","modifiedBy":"ONEDATA","dateModified":"2008-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E25B7761-FFDB-0966-E040-BB89AD434206","latestVersionIndicator":"Yes","beginDate":"2008-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-25","modifiedBy":"MALUMK","dateModified":"2019-03-22","changeDescription":". Added 2 PVs for 2100r4. AK 11/11/15 Added PV for 2400r6. AK 1/2/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the the primary indic","type":"Preferred Question Text","description":"What is the the primary indication for the hematopoietic cell transplant?","url":null,"context":"NHLBI"},{"name":"What was the primary reason for the HCT?","type":"Application Standard Question Text","description":"What was the primary reason for the HCT?","url":null,"context":"NHLBI"},{"name":"What was the primary reason for the HCT?","type":"Alternate Question Text","description":"What was the primary reason for the HCT?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8381E04B-AFD9-71F3-E053-F662850A5B99","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-07","modifiedBy":"KUMMEROA","dateModified":"2019-12-31","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def. 03/07/2019 KMM. Updated DEC. System generated def displayed as alt def. Human Readable definition revised.  Def different for Transplantation due to NCIt updates. 04/03/2019 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}